Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This is a phase I study to investigate the safety and pharmacokinetics of weekly
5-fluorouracil (5-FU) administered as a bolus dose in children and young adults with
recurrent or refractory ependymoma. The results from this study will inform a subsequent
phase II St. Jude investigator-initiated trial.